Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Sunflower Pharmaceutical Group Co.,Ltd

Market Cap 7.26B 1.07B 927M 854M 800M 1.5B 102B 1.52B 10.09B 3.93B 49.67B 4.03B 3.94B 172B P/E Ratio 2024
24.4x
P/E Ratio 2025 -33.6x
Enterprise Value 4.77B 705M 609M 561M 525M 985M 67.04B 1B 6.63B 2.58B 32.63B 2.65B 2.59B 113B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day+2.30%
1 week-2.58%
Current month-4.89%
1 month-7.92%
3 months-1.97%
6 months-17.83%
Current year-15.78%
1 week 11.9
Extreme 11.9
12.83
1 month 11.9
Extreme 11.9
13.49
Current year 11.7
Extreme 11.7
15.19
1 year 11.7
Extreme 11.7
17.17
3 years 11.7
Extreme 11.7
30.79
5 years 11.7
Extreme 11.7
31.48
10 years 11.7
Extreme 11.7
31.48
Manager TitleAgeSince
Chief Executive Officer 44 2019-01-06
Director of Finance/CFO 49 2021-12-05
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 66 2014-03-25
Director/Board Member 64 2017-09-25
Director/Board Member 44 2017-09-25
Date Insider Type Main position Quantity % Market Cap.
24-07-16Buy 500 0.0001%
20-01-21Sell

Director

246,300 0.0462%
19-12-31Sell 1,095,000 0.2053%
Change 5-day change 1-year change 3-year change Capi.($)
+2.30%-2.58%-21.32%-48.38% 1.07B
+0.10%+3.67%-10.44%-4.94% 13.34B
+2.67%-0.32%-32.02%-55.61% 5.06B
+0.90%+1.77%-6.31%+2.21% 4.79B
+3.15%+2.01%+8.20%-40.65% 3.88B
+2.11%-2.30%+13.25%-16.65% 3.86B
+2.81%-3.14%-1.45%-7.35% 3.69B
+1.48%+1.55%-10.11%-0.96% 3.18B
+5.11%+1.13%-8.04%-26.72% 2.37B
+0.87%-4.27%-11.89%+28.18% 1.73B
Average +2.15%+0.87%-8.01%-17.09% 4.3B
Weighted average by Cap. +1.64%+1.57%-8.11%-15.24%

Financials

2024 2025
Net sales 3.38B 499M 431M 397M 372M 697M 47.43B 708M 4.69B 1.83B 23.09B 1.87B 1.83B 79.94B 2.32B 343M 296M 273M 255M 478M 32.56B 486M 3.22B 1.26B 15.85B 1.29B 1.26B 54.87B
Net income 492M 72.71M 62.8M 57.87M 54.17M 102M 6.91B 103M 683M 266M 3.36B 273M 267M 11.65B -258M -38.1M -32.91M -30.32M -28.39M -53.2M -3.62B -54.02M -358M -140M -1.76B -143M -140M -6.1B
Net Debt -2.29B -338M -292M -269M -252M -472M -32.16B -480M -3.18B -1.24B -15.65B -1.27B -1.24B -54.2B -2.49B -368M -318M -293M -274M -514M -35.01B -522M -3.46B -1.35B -17.04B -1.38B -1.35B -59B
Logo Sunflower Pharmaceutical Group Co.,Ltd
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
26-06-12 12.44 ¥ +2.30% 6,821,623
26-06-11 12.16 ¥ -2.33% 4,034,100
26-06-10 12.45 ¥ -0.80% 3,594,200
26-06-09 12.55 ¥ -1.49% 4,605,630
26-06-08 12.74 ¥ -0.23% 4,147,000

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!